Home » Global Tolerated Dose Tenders and GPN from across the Globe

Global Tolerated Dose Tenders and GPN from across the Globe

TendersOnTime provides latest updates on Global Tolerated Dose Tenders, Contract Awards and various other opportunities related to Tolerated Dose. The information on Tolerated Dose tenders is collected from various sources viz: government tenders portal, tender bulletin and public procurement websites.

Services of the Effect of Compound X in Mice for the Biomedicine Department of the Faculty of Medicine and Health Sciences of the University of Barcelona. Specific Services (sell Det ...

Deadline: 26 Jan 2024

Spain

Deadline: 26 Jan 2024

TOT Reference No.: 95118379

View Details

Burosumab Reference Chisel: 27-vo/2023/rdfn

Deadline: 09 Oct 2023

Slovakia

Deadline: 09 Oct 2023

TOT Reference No.: 88805799

View Details

Burosumab

Deadline: 09 Oct 2023

Slovakia

Deadline: 09 Oct 2023

TOT Reference No.: 88736619

View Details

Developing Humanized Mouse Models for Nnmt and Sult1a1

Deadline: 07 Sep 2023

USA

Deadline: 07 Sep 2023

TOT Reference No.: 88435653

View Details

Developing Humanized Mouse Models for Nnmt and Sult1a1

Deadline: 05 Sep 2023

USA

Deadline: 05 Sep 2023

TOT Reference No.: 88160241

View Details

Developing Humanized Mouse Models for Nnmt and Sult1a1

Deadline: 01 Sep 2023

USA

Deadline: 01 Sep 2023

TOT Reference No.: 87848039

View Details

Maximally Tolerated Dose (Mtd) and 14-Day Dose Range-Finding (Drf) Toxicity Study in Male and Female Rats for Ncats Etb.

Deadline: 09 Aug 2023

USA

Deadline: 09 Aug 2023

TOT Reference No.: 86694362

View Details

Maximally Tolerated Dose (Mtd) and 14-Day Dose Range-Finding (Drf) Toxicity Study in Male and Female Rats for Ncats Etb.

Deadline: 03 Aug 2023

USA

Deadline: 03 Aug 2023

TOT Reference No.: 86564157

View Details

Small Business Sources Sought: Phase i Clinical Trials for Development of Neurotherapeutics

Deadline: 02 Dec 2022

USA

Deadline: 02 Dec 2022

TOT Reference No.: 74833490

View Details

R&D Sources Sought: Phase i Clinical Trials for Development of Neurotherapeutics

Deadline: 02 Dec 2022

USA

Deadline: 02 Dec 2022

TOT Reference No.: 74833494

View Details

Prev
1
2
....
4
Next

Deadline: {{rowDetails.Bid_Deadline_1}}

{{rowDetails.Country_Name}}

Deadline: {{rowDetails.Bid_Deadline_1}}

TOT Reference No.: {{rowDetails.ID}}

View Details

No Data Found..!!

Prev
{{ $index+1 }}
....
4
Next

Tenders By Region

AFRICA TENDERS

AMERICAS TENDERS

Tenders By Country

Tenders By Funding Agency

Tenders By Geo-Political Region

Global Tolerated Dose Tenders and GPN from across the Globe

Browse Tenders

Get A Callback Within 24 Hours

OR

OR

Global Tolerated Dose Tenders and GPN from across the Globe

Browse Tenders

Get A Callback Within 24 Hours